An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer

Research output: Contribution to journal › Article (Academic Journal) › peer-review

95 Citations (Scopus)

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{192213479149438088dd8a6a94f8248b,

title = "An open-label phase II study of low-dose thalidomide in androgen-independent prostate cancer",

author = "Marcus Drake and Wendy Robson and P Mehta and I Schofield and DE Neal and HY Leung",

year = "2003",

language = "English",

volume = "88",

pages = "822--827",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Springer Nature",

}